Phenotyping and Genotyping of HNA: Prevalence, Risk of Alloimmunization, and HNA Incompatibilities in Indians.
Human neutrophil alloantigens
Human neutrophil antigen alloimmunization
Indians
Neutropenia
Transfusion-related acute lung injury
Journal
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
ISSN: 1660-3796
Titre abrégé: Transfus Med Hemother
Pays: Switzerland
ID NLM: 101176417
Informations de publication
Date de publication:
Feb 2023
Feb 2023
Historique:
received:
14
03
2022
accepted:
20
06
2022
entrez:
23
2
2023
pubmed:
24
2
2023
medline:
24
2
2023
Statut:
epublish
Résumé
Antibodies to human neutrophil alloantigens (HNA) are involved in the pathophysiology of several clinical conditions including transfusion-related acute lung injury (TRALI), alloimmune and autoimmune neutropenia, and febrile nonhemolytic transfusion reactions leading to neutropenia. The cognate antigens are polymorphic structures expressed on several glycoproteins on the neutrophils, i.e., antigens HNA-1a, -1b, -1c, and -1d on Fc-γ-receptor IIIb; HNA-2 on CD177; HNA-3a and -3b on choline transporter-like protein 2; HNA-4a and -4b on CD11b/αM subunit of the αMβ2-integrin (CD11b/CD18, Mac-1, CR3); and HNA-5a and -5b on αL-subunit (CD11a) of the αLβ2 integrin (CD11a/CD18), leukocyte function associated molecule (LFA)-1. Currently, there is a lacuna of diagnostic methods for detection of HNA in India. This study aimed to determine the HNA frequencies in Indians, estimate the risk of alloimmunization, and prepare typed neutrophil panels, which can be used to detect HNA antibodies in neutropenia cases. EDTA blood samples were collected from random 1,054 blood donors. HNA-2 was phenotyped on fresh EDTA samples using FITC labelled monoclonal anti-CD177 by flowcytometry. HNA-1 ( Allele frequencies of This is the first study in India to report the frequencies of HNA among blood donors. Typed neutrophil panels identified in the present study will enable us to investigate suspected cases of immune neutropenia in future.
Sections du résumé
Background
UNASSIGNED
Antibodies to human neutrophil alloantigens (HNA) are involved in the pathophysiology of several clinical conditions including transfusion-related acute lung injury (TRALI), alloimmune and autoimmune neutropenia, and febrile nonhemolytic transfusion reactions leading to neutropenia. The cognate antigens are polymorphic structures expressed on several glycoproteins on the neutrophils, i.e., antigens HNA-1a, -1b, -1c, and -1d on Fc-γ-receptor IIIb; HNA-2 on CD177; HNA-3a and -3b on choline transporter-like protein 2; HNA-4a and -4b on CD11b/αM subunit of the αMβ2-integrin (CD11b/CD18, Mac-1, CR3); and HNA-5a and -5b on αL-subunit (CD11a) of the αLβ2 integrin (CD11a/CD18), leukocyte function associated molecule (LFA)-1. Currently, there is a lacuna of diagnostic methods for detection of HNA in India. This study aimed to determine the HNA frequencies in Indians, estimate the risk of alloimmunization, and prepare typed neutrophil panels, which can be used to detect HNA antibodies in neutropenia cases.
Material and Methods
UNASSIGNED
EDTA blood samples were collected from random 1,054 blood donors. HNA-2 was phenotyped on fresh EDTA samples using FITC labelled monoclonal anti-CD177 by flowcytometry. HNA-1 (
Results
UNASSIGNED
Allele frequencies of
Conclusion
UNASSIGNED
This is the first study in India to report the frequencies of HNA among blood donors. Typed neutrophil panels identified in the present study will enable us to investigate suspected cases of immune neutropenia in future.
Identifiants
pubmed: 36818775
doi: 10.1159/000525654
pii: tmh-0050-0030
pmc: PMC9911994
doi:
Types de publication
Journal Article
Langues
eng
Pagination
30-38Informations de copyright
Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Vox Sang. 2005 Jan;88(1):52-9
pubmed: 15663723
Pediatr Allergy Immunol. 2011 Aug;22(5):494-6
pubmed: 21771084
Transfusion. 2014 Jun;54(6):1619-21
pubmed: 24236643
CSH Protoc. 2006 Jun 01;2006(1):
pubmed: 22485786
Korean J Lab Med. 2006 Apr;26(2):114-8
pubmed: 18156711
Transfusion. 2012 May;52(5):1106-11
pubmed: 22040064
Tissue Antigens. 1979 Feb;13(2):129-34
pubmed: 87023
Tissue Antigens. 2011 Dec;78(6):416-20
pubmed: 22077622
Blood Transfus. 2015 Oct;13(4):610-5
pubmed: 26057487
Transfusion. 2003 May;43(5):641-5
pubmed: 12702187
Blood Transfus. 2014 Jan;12 Suppl 1:s286-91
pubmed: 23399362
Transfus Med. 2020 Feb;30(1):30-36
pubmed: 31777111
PLoS Genet. 2015 May 29;11(5):e1005255
pubmed: 26024230
Vox Sang. 2009 Jul;97(1):69-76
pubmed: 19320901
Vox Sang. 2013 Jul;105(1):65-72
pubmed: 23398146
Ann Lab Med. 2018 Jul;38(4):362-366
pubmed: 29611387
Transfus Med. 2018 Feb;28(1):47-55
pubmed: 28589653
Transfus Med. 1992 Jun;2(2):143-9
pubmed: 1284978
Tissue Antigens. 2012 Sep;80(3):249-53
pubmed: 22703110
Semin Hematol. 1974 Jul;11(3):281-90
pubmed: 4134542
Transfus Med. 2019 Apr;29(2):110-115
pubmed: 30974499
Vox Sang. 1978 Jul-Aug;35(1-2):13-7
pubmed: 78583
Transfus Apher Sci. 2020 Apr;59(2):102651
pubmed: 31606336
Transfusion. 2016 Aug;56(8):2127-32
pubmed: 27385476
Tissue Antigens. 2009 Nov;74(5):404-7
pubmed: 19737365
Blood Transfus. 2014 Jan;12 Suppl 1:s292-8
pubmed: 23867183
Tissue Antigens. 2005 Feb;65(2):178-82
pubmed: 15713217
Transfusion. 2011 Nov;51(11):2391-7
pubmed: 21564101
Tissue Antigens. 2012 Oct;80(4):336-40
pubmed: 22776008
Int J Immunogenet. 2017 Dec;44(6):274-278
pubmed: 29057627
PLoS Genet. 2016 May 26;12(5):e1006067
pubmed: 27227454
Transfusion. 1996 Oct;36(10):895-9
pubmed: 8863777
Transfusion. 2016 Jun;56(6):1477-9
pubmed: 27039828
PLoS One. 2015 Jan 21;10(1):e0116905
pubmed: 25608003
Transfusion. 2011 Jun;51(6):1271-7
pubmed: 21166683
Infect Immun. 2018 Jul 23;86(8):
pubmed: 29784860
Transfusion. 2002 May;42(5):651-7
pubmed: 12084175
Transfusion. 1990 Nov-Dec;30(9):848-9
pubmed: 1700502
J Clin Invest. 1971 May;50(5):1108-15
pubmed: 5552408
Transfus Med. 2018 Aug;28(4):310-318
pubmed: 29280200
Vox Sang. 1994;66(3):247
pubmed: 7518626
J Clin Invest. 1966 Nov;45(11):1741-50
pubmed: 5926443
Transfusion. 2011 Mar;51(3):574-7
pubmed: 20735765
Transfusion. 2000 Jun;40(6):654-62
pubmed: 10864984
Transfus Med. 2003 Feb;13(1):49-52
pubmed: 12581454
Vox Sang. 2010 Feb;98(2):160-6
pubmed: 19695014
Transfusion. 1989 Sep;29(7):654
pubmed: 2773034
Transfusion. 2006 Sep;46(9):1515-20
pubmed: 16965578
Tissue Antigens. 2000 Aug;56(2):143-8
pubmed: 11019914
Clin Lab. 2018 Apr 1;64(4):597-601
pubmed: 29739087
Transfusion. 2004 Jan;44(1):77-82
pubmed: 14692971
Blood. 1999 Feb 1;93(3):1115-6
pubmed: 10025985
Vox Sang. 2000;79(2):112-5
pubmed: 11054050
Vox Sang. 2008 May;94(4):277-85
pubmed: 18208407
J Korean Med Sci. 2006 Aug;21(4):627-32
pubmed: 16891804
Immunohematology. 1997;13(1):15-6
pubmed: 15387793
Transfusion. 1999 Jun;39(6):593-8
pubmed: 10378839
J Clin Lab Anal. 2019 Jan;33(1):e22651
pubmed: 30105756